Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:50 pm Purchase |
2024-09-30 | 13G | Aldeyra Therapeutics, Inc. ALDX |
Perceptive Advisors LLC | 9,275,851 15.600% |
682,265 (+7.94%) |
Filing History |
| 2024-11-14 4:50 pm Purchase |
2024-09-30 | 13G | Precision BioSciences, Inc. DTIL |
Perceptive Advisors LLC | 426,293 5.900% |
426,293 (New Position) |
Filing History |
| 2024-11-14 4:50 pm Purchase |
2024-09-30 | 13G | Verona Pharma plc VRNA |
Perceptive Advisors LLC | 6,565,933 8.100% |
1,447,788 (+28.29%) |
Filing History |
| 2024-11-14 4:50 pm Purchase |
2024-09-30 | 13G | Nuvalent, Inc. NUVL |
Perceptive Advisors LLC | 2,979,235 4.600% |
61,244 (+2.10%) |
Filing History |
| 2024-11-14 4:50 pm Purchase |
2024-09-30 | 13G | Evolus, Inc. EOLS |
Perceptive Advisors LLC | 5,356,622 8.500% |
1,393,198 (+35.15%) |
Filing History |
| 2024-11-14 4:50 pm Purchase |
2024-09-30 | 13G | Applied Therapeutics, Inc. APLT |
Perceptive Advisors LLC | 10,005,000 8.500% |
5,424,751 (+118.44%) |
Filing History |
| 2024-11-14 4:50 pm Sale |
2024-05-30 | 13G | Inhibrx Biosciences, Inc. INBX |
Perceptive Advisors LLC | 0 0.000% |
-4,776,306 (Position Closed) |
Filing History |
| 2024-11-14 4:41 pm Unchanged |
2024-11-14 | 13D | Astria Therapeutics, Inc. ATXS |
Perceptive Advisors LLC | 6,485,420 11.500% |
0 (Unchanged) |
Filing History |
| 2024-11-14 4:33 pm Purchase |
2024-09-30 | 13G | Spyre Therapeutics, Inc. SYRE |
Perceptive Advisors LLC | 2,872,547 5.700% |
265,868 (+10.20%) |
Filing History |
| 2024-11-14 4:31 pm Purchase |
2024-09-30 | 13G | Forte Biosciences, Inc. FBRX |
Perceptive Advisors LLC | 151,433 9.990% |
151,433 (New Position) |
Filing History |
| 2024-11-14 4:31 pm Sale |
2024-09-30 | 13G | Arcellx, Inc. ACLX |
Perceptive Advisors LLC | 3,888,669 7.200% |
-656,140 (-14.44%) |
Filing History |
| 2024-11-14 4:31 pm Unchanged |
2024-11-14 | 13D | Nautilus Biotechnology, Inc. NAUT |
Perceptive Advisors LLC | 12,594,211 10.000% |
0 (Unchanged) |
Filing History |
| 2024-11-14 4:30 pm Purchase |
2024-08-07 | 13D | Soleno Therapeutics, Inc. SLNO |
Perceptive Advisors LLC | 3,454,976 8.800% |
380,434 (+12.37%) |
Filing History |
| 2024-11-13 4:30 pm Purchase |
2024-09-30 | 13G | Adagio Medical Holdings, Inc. ADGM |
Perceptive Advisors LLC | 15,257,488 76.400% |
15,257,488 (New Position) |
Filing History |
| 2024-10-31 4:16 pm Purchase |
2024-10-30 | 13D | Athira Pharma, Inc. ATHA |
Perceptive Advisors LLC | 5,479,348 14.200% |
20,900 (+0.38%) |
Filing History |
| 2024-10-29 5:27 pm Purchase |
2024-10-22 | 13G | Ensysce Biosciences, Inc. ENSC |
Perceptive Advisors LLC | 86,667 8.700% |
86,667 (New Position) |
Filing History |
| 2024-10-25 5:38 pm Purchase |
2024-10-18 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
Perceptive Advisors LLC | 4,458,741 6.500% |
2,589,616 (+138.55%) |
Filing History |
| 2024-10-22 4:15 pm Purchase |
2024-10-21 | 13G | Inhibikase Therapeutics, Inc. IKT |
Perceptive Advisors LLC | 6,799,944 9.990% |
6,799,944 (New Position) |
Filing History |
| 2024-10-17 4:15 pm Purchase |
2024-10-15 | 13D | Immatics N.V. IMTX |
Perceptive Advisors LLC | 9,469,705 7.900% |
1,298,859 (+15.90%) |
Filing History |
| 2024-10-16 1:14 pm Purchase |
2024-10-14 | 13G | Bright Minds Biosciences Inc. DRUG |
Perceptive Advisors LLC | 430,000 9.600% |
430,000 (New Position) |
Filing History |